Skip to main content

1620 INVESTMENT ADVISORS, INC.

Position in ABBV — AbbVie Inc.

CIK 1907281 PLYMOUTH, MA

Position in ABBV

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$1,798,219
+$159,867 QoQ
Shares Held
7,146
-5.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#2,049
of 4,153 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $6,968,762 across 10 Drug Manufacturers - General names. ABBV ranks #1 (25.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
7,146 $1,798,219

All Filings in ABBV

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,798,219 7,146
2026-03-31 $1,638,352 7,533
2025-12-31 $1,717,559 7,517
2025-09-30 $1,743,496 7,530
2025-06-30 $1,420,549 7,653
2025-03-31 $1,569,304 7,490
2024-12-31 $1,320,488 7,431
2024-09-30 $1,493,738 7,564
2024-06-30 $1,433,049 8,355
2024-03-31 $1,374,126 7,546
2023-12-31 $1,150,342 7,423
2023-09-30 $1,148,954 7,708
2023-06-30 $1,046,852 7,770
2023-03-31 $1,245,954 7,818
2022-12-31 $1,259,426 7,793
2022-09-30 $1,026,169 7,646
2022-06-30 $1,162,331 7,589
2022-03-31 $1,638,607 10,108
2021-12-31 $1,368,623 10,108